Captrust Financial Advisors Vyant Bio, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	BUY	$0.52 - $0.89 $105,391 - $180,380	202,675 Added 405350.0%	202,725 $113,000
Q2 2022 Aug 23, 2022	SELL	$0.62 - $1.37 $45 - $101	-74 Reduced 59.68%	50 $0
Q1 2022 May 16, 2022	BUY	$0.99 - $1.61 $73 - $119	74 Added 148.0%	124 $0
Q1 2021 May 17, 2021	BUY	$2.89 - $8.6 $144 - $430	50 New	50 $0

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.